Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Evaluation of Proinflammatory Cytokines and Adverse Events in Healthy Volunteers upon Inhalation of Antituberculosis Drugs.

Srichana T, Ratanajamit C, Juthong S, Suwandecha T, Laohapojanart N, Pungrassami P, Padmavathi AR.

Biol Pharm Bull. 2016;39(11):1815-1822.

3.

Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.

Moolphate S, Lawpoolsri S, Pungrassami P, Sanguanwongse N, Yamada N, Kaewkungwal J.

Glob J Health Sci. 2013 Mar 25;5(4):60-70. doi: 10.5539/gjhs.v5n4p60.

4.

Physicians' practices regarding management of antituberculosis drug-induced hepatotoxicity.

Thongraung W, Lertphongpiroon W, Pungrassami P, Ratanajamit C.

Southeast Asian J Trop Med Public Health. 2012 May;43(3):724-34.

PMID:
23077853
6.

Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.

Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1540-5, i. doi: 10.5588/ijtld.10.0273.

7.

Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members.

Kipp AM, Pungrassami P, Nilmanat K, Sengupta S, Poole C, Strauss RP, Chongsuvivatwong V, Van Rie A.

BMC Public Health. 2011 Aug 30;11:675. doi: 10.1186/1471-2458-11-675.

8.

Tuberculosis and AIDS stigma among patients who delay seeking care for tuberculosis symptoms.

Pungrassami P, Kipp AM, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A.

Int J Tuberc Lung Dis. 2010 Feb;14(2):181-7.

9.

Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.

Changsan N, Nilkaeo A, Pungrassami P, Srichana T.

J Drug Target. 2009 Dec;17(10):751-62. doi: 10.3109/10611860903079462.

PMID:
19863196
10.

Village health volunteer participation in tuberculosis control in southern thailand.

Phomborphub B, Pungrassami P, Boonkitjaroen T.

Southeast Asian J Trop Med Public Health. 2008 May;39(3):542-8.

PMID:
18564696
11.

Measuring stigma associated with tuberculosis and HIV/AIDS in southern Thailand: exploratory and confirmatory factor analyses of two new scales.

Van Rie A, Sengupta S, Pungrassami P, Balthip Q, Choonuan S, Kasetjaroen Y, Strauss RP, Chongsuvivatwong V.

Trop Med Int Health. 2008 Jan;13(1):21-30. doi: 10.1111/j.1365-3156.2007.01971.x.

12.

Under- and over-consumption intermittent TB treatment among rural TB patients in south-west China.

Wang YY, Liabsuetrakul T, Chongsuvivatwong V, Pungrassami P, He CY, Ren LJ, Yang HZ.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1345-51.

PMID:
18034957
13.

Social impact of tuberculosis in southern Thailand: views from patients, care providers and the community.

Sengupta S, Pungrassami P, Balthip Q, Strauss R, Kasetjaroen Y, Chongsuvivatwong V, Van Rie A.

Int J Tuberc Lung Dis. 2006 Sep;10(9):1008-12.

PMID:
16964792
14.

Deteriorated tuberculosis drugs and management system problems in lower southern Thailand.

Rookkapan K, Chongsuvivatwong V, Kasiwong S, Pariyawatee S, Kasetcharoen Y, Pungrassami P.

Int J Tuberc Lung Dis. 2005 Jun;9(6):654-60.

PMID:
15971393
15.
16.

Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers.

Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J, Sørensen HT.

Int J Tuberc Lung Dis. 2002 May;6(5):389-95.

PMID:
12019914
17.

Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand?

Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J.

Trop Med Int Health. 2002 Mar;7(3):271-9.

Supplemental Content

Loading ...
Support Center